Qiu Li
6PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 14, 2025
Targeting the poliovirus receptor to activate T cells and induce myeloid-derived suppressor cells to differentiate to pro-inflammatory macrophages via the IFN-γ-p-STAT1-IRF8 axis in cancer therapy.Mingyang Feng, Qizhi Ma, Benxia Zhang
|Sep 20, 2024
Cost-effectiveness analysis of durvalumab plus tremelimumab as first-line therapy in patients with unresectable hepatocellular carcinoma.Weiting Liao, Huiqiong Xu, David Hutton
|Aug 04, 2022
Atezolizumab with chemotherapy in first-line treatment for metastatic urothelial cancer: a cost-effectiveness analysis.Peng-Fei Zhang, Feng Wen, Qiu-Ji Wu
|Mar 02, 2022
Reversing chemokine/chemokine receptor mismatch to enhance the antitumor efficacy of CAR-T cells.Peng-Fei Zhang, Chuang Wang, Le Zhang
|Jan 08, 2021
Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgen-signaling-targeted inhibitor resistance.Peng-Fei Zhang, Dan Xie, Qiu Li
|Jul 31, 2020
Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.Peng-Fei Zhang, Dan Xie, Qiu Li
Pageof 1
